Biologically Active Small Molecules

Can be formed by the dimerization of two molecules of &alpha-trans-cinnamic acid significantly blocks inflammatory pain while having little effect on neurogenic pain, as indicated by the formalin test in mice.

Can be formed by the dimerization of two molecules of &alpha-trans-cinnamic acid significantly blocks inflammatory pain while having little effect on neurogenic pain, as indicated by the formalin test in mice.

Can be formed by the dimerization of two molecules of &alpha-trans-cinnamic acid significantly blocks inflammatory pain while having little effect on neurogenic pain, as indicated by the formalin test in mice.

A major hepatic metabolite of zearalenone that is a less potent agonist of estrogen receptors than the parent compound has pronounced effects on uterotropic activity, sperm motility, and preimplantation embryonic development.

A major hepatic metabolite of zearalenone that is a less potent agonist of estrogen receptors than the parent compound has pronounced effects on uterotropic activity, sperm motility, and preimplantation embryonic development.

A major hepatic metabolite of zearalenone that is a less potent agonist of estrogen receptors than the parent compound has pronounced effects on uterotropic activity, sperm motility, and preimplantation embryonic development.

Buspirone is an azapirone anxiolytic that acts as a partial agonist at 5-HT1A receptors and a1-adrenergic receptors and an antagonist at D2/3/4 receptors. Buspirone is clinically used to treat anxiety.

Buspirone is an azapirone anxiolytic that acts as a partial agonist at 5-HT1A receptors and a1-adrenergic receptors and an antagonist at D2/3/4 receptors. Buspirone is clinically used to treat anxiety.

Alfuzosin is an a1-adrenergic receptor antagonist that is used clinically to treat benign prostatic hyperplasia (BPH) it relaxes prostatic smooth muscle and increases the urinary flow rate. Alfuzosin also delays cardiac repolarization by increasing

Alfuzosin is an a1-adrenergic receptor antagonist that is used clinically to treat benign prostatic hyperplasia (BPH) it relaxes prostatic smooth muscle and increases the urinary flow rate. Alfuzosin also delays cardiac repolarization by increasing

Alfuzosin is an a1-adrenergic receptor antagonist that is used clinically to treat benign prostatic hyperplasia (BPH) it relaxes prostatic smooth muscle and increases the urinary flow rate. Alfuzosin also delays cardiac repolarization by increasing

Atenolol is an antagonist at ß1-adrenergic receptors that is clinically acceptable for the treatment of hypertension, angina, myocardial infarction, and tachycardia. Atenolol exhibits antihypertensive and anti-anginal activities, primarily through